(Q36590609)

15 August 2017

1 reference

title

Management of venous thromboembolism in the elderly (English)

1 reference

15 August 2017

main subject

venous thromboembolism

1 reference

Alex C Spyropoulos

1

1 reference

15 August 2017

Geno Merli

series ordinal

2

1 reference

15 August 2017

publication date

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

23

1 reference

15 August 2017

issue

8

1 reference

15 August 2017

page(s)

651-671

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200623080-00003

15 August 2017

exact match

0 references

cites work

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

1 reference

12 December 2020

A disease management protocol for outpatient perioperative bridge therapy with enoxaparin in patients requiring temporary interruption of long-term oral anticoagulation

1 reference

12 December 2020

The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency

1 reference

12 December 2020

An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study

1 reference

12 December 2020

Pharmacological thromboembolic prophylaxis in a medical ward: room for improvement

1 reference

12 December 2020

Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.

1 reference

12 December 2020

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

1 reference

12 December 2020

Provider preferences for DVT prophylaxis

1 reference

12 December 2020

Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?

1 reference

12 December 2020

Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism

1 reference

12 December 2020

Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Why don't physicians follow clinical practice guidelines? A framework for improvement

1 reference

12 December 2020

Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy

1 reference

12 December 2020

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

1 reference

12 December 2020

Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale.

1 reference

12 December 2020

Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients

1 reference

12 December 2020

Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement.

1 reference

12 December 2020

Underuse of venous thromboembolism prophylaxis for general surgery patients: physician practices in the community hospital setting

1 reference

12 December 2020

Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial

1 reference

12 December 2020

Deep vein thrombosis in elderly patients hospitalized in subacute care facilities: a multicenter cross-sectional study of risk factors, prophylaxis, and prevalence

1 reference

12 December 2020

Reduction of venous thromboembolism following prolonged prophylaxis with the low molecular weight heparin Certoparin after endoprothetic joint replacement or osteosynthesis of the lower limb in elderly patients

1 reference

12 December 2020

Challenges in the prevention of venous thromboembolism in the elderly

1 reference

12 December 2020

Anticoagulants in older patients. A safety perspective

1 reference

12 December 2020

Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.

1 reference

12 December 2020

Trials and tribulations of non-inferiority: the ximelagatran experience

1 reference

12 December 2020

Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin)

1 reference

12 December 2020

Management of acute proximal deep vein thrombosis: pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs inpatient treatment with unfractionated heparin

1 reference

12 December 2020

Thirty-day case-fatality rates for pulmonary embolism in the elderly

1 reference

12 December 2020

Electronic alerts to prevent venous thromboembolism among hospitalized patients.

1 reference

12 December 2020

Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease

1 reference

12 December 2020

Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvement

1 reference

12 December 2020

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism

1 reference

12 December 2020

Systematic overview of warfarin and its drug and food interactions

1 reference

12 December 2020

The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly.

1 reference

12 December 2020

Changing clinical practice. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism.

1 reference

12 December 2020

Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study.

1 reference

12 December 2020

Treatment of deep venous thrombosis and pulmonary embolism with low molecular weight heparin in the geriatric patient population

1 reference

12 December 2020

Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials

1 reference

12 December 2020

Elevated factor VIII is a risk factor for idiopathic venous thromboembolism in Canada - is it necessary to define a new upper reference range for factor VIII?

1 reference

12 December 2020

Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism

1 reference

12 December 2020

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study

1 reference

12 December 2020

Effect of age on the incidence of venous thromboembolism after major surgery

1 reference

12 December 2020

Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period

1 reference

12 December 2020

Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery

1 reference

12 December 2020

Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study

1 reference

12 December 2020

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

1 reference

12 December 2020

Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators

1 reference

12 December 2020

Relation of the Prothrombotic State to Increasing Age (from the Framingham Offspring Study)

1 reference

12 December 2020

1 reference

12 December 2020

Safety profile of tinzaparin administered once daily at a standard curative dose in two hundred very elderly patients

1 reference

12 December 2020

Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran

1 reference

12 December 2020

Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy

1 reference

12 December 2020

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

1 reference

12 December 2020

Safety of treatment with oral anticoagulants in the elderly. A systematic review

1 reference

12 December 2020

Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants.

1 reference

12 December 2020

Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial

1 reference

12 December 2020

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer

1 reference

12 December 2020

Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

1 reference

12 December 2020

Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism

1 reference

12 December 2020

Enoxaparin or fondaparinux for thrombosis prevention after orthopaedic surgery

1 reference

12 December 2020

Effect of age on the performance of a diagnostic strategy based on clinical probability, spiral computed tomography and venous compression ultrasonography: the ESSEP study.

1 reference

12 December 2020

Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.

1 reference

12 December 2020

Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis

1 reference

12 December 2020

A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy.

1 reference

12 December 2020

2002 National Hospital Discharge Survey

1 reference

12 December 2020

Meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery

1 reference

12 December 2020

Renal function in the elderly (>70 years old) measured by means of iohexol clearance, serum creatinine, serum urea and estimated clearance

1 reference

12 December 2020

Ximelagatran: an eulogy

1 reference

12 December 2020

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.

1 reference

12 December 2020

Risks of oral anticoagulant therapy with increasing age.

1 reference

12 December 2020

Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group

1 reference

12 December 2020

Enoxaparin monotherapy without oral anticoagulation to treat acute symptomatic pulmonary embolism.

1 reference

12 December 2020

Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study

1 reference

12 December 2020

Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

1 reference

12 December 2020

Low-molecular-weight heparin versus unfractionated heparin in the treatment of patients with acute pulmonary thromboembolism

1 reference

12 December 2020

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

1 reference

12 December 2020

Reduced efficacy of clinical probability score and D-dimer assay in elderly subjects suspected of having deep vein thrombosis

1 reference

12 December 2020

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients

1 reference

12 December 2020

Suboptimal prescribing in elderly outpatients: potentially harmful drug-drug and drug-disease combinations

1 reference

12 December 2020

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

The incidence of venous thromboembolism among Factor V Leiden carriers: a community-based cohort study

1 reference

12 December 2020

Differential value of risk factors and clinical signs for diagnosing pulmonary embolism according to age.

1 reference

12 December 2020

The efficacy of prophylaxis with low-dose warfarin for prevention of pulmonary embolism following total hip arthroplasty.

1 reference

12 December 2020

Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group

1 reference

12 December 2020

The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism

1 reference

12 December 2020

Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial

1 reference

12 December 2020

Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease

1 reference

12 December 2020

Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population

1 reference

12 December 2020

Acute pulmonary embolism in elderly: clinical characteristics and outcome

1 reference

12 December 2020

Antithrombotic drugs for older subjects. Guidelines formulated jointly by the Italian Societies of Haemostasis and Thrombosis (SISET) and of Gerontology and Geriatrics (SIGG)

1 reference

12 December 2020

A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group

1 reference

12 December 2020

Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease

1 reference

12 December 2020

Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery

1 reference

12 December 2020

Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study

1 reference

12 December 2020

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

1 reference

12 December 2020

Serum creatinine is an inadequate screening test for renal failure in elderly patients

1 reference

12 December 2020

Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.

1 reference

12 December 2020

Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction

1 reference

12 December 2020

Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-blind trial

1 reference

12 December 2020

Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study

1 reference

12 December 2020

Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin

1 reference

12 December 2020

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

1 reference

12 December 2020

Risk factors for deep vein thrombosis in inpatients aged 65 and older: a case-control multicenter study

1 reference

12 December 2020

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

1 reference

12 December 2020

Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials

1 reference

12 December 2020

Pulmonary embolism in medical patients: improved diagnosis and the role of low-molecular-weight heparin in prevention and treatment

1 reference

12 December 2020

Pulmonary embolism in the elderly: clinical, instrumental and laboratory aspects

1 reference

12 December 2020

Antithrombotic and thrombolytic therapy: from evidence to application: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry

1 reference

12 December 2020

The epidemiology of venous thromboembolism in the community

1 reference

12 December 2020

Elderly patients treated with tinzaparin (Innohep) administered once daily (175 anti-Xa IU/kg): anti-Xa and anti-IIa activities over 10 days

1 reference

12 December 2020

Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators

1 reference

12 December 2020

Deep venous thrombosis in elderly hospitalized patients: prevalence and clinical features

1 reference

12 December 2020

A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism

1 reference

12 December 2020

Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis

1 reference

12 December 2020

Risk assessment model for venothromboembolism in post-hospitalized patients

1 reference

12 December 2020

Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis.

1 reference

12 December 2020

Venous thromboembolism according to age: the impact of an aging population.

1 reference

12 December 2020

Aging and heparin-related bleeding

1 reference

12 December 2020

10.2165/00002512-200623080-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

1035339125

0 references

1 reference